Science Daily - Heart Disease
MARCH 20, 2024
A study of over 20,000 adults found that those who followed an 8-hour time-restricted eating schedule, a type of intermittent fasting, had a 91% higher risk of death from cardiovascular disease.
Med Page Today
MARCH 20, 2024
(MedPage Today) -- The FDA has approved aprocitentan (Tryvio), making it the first endothelin receptor antagonist for the treatment of high blood pressure (BP), Idorsia Pharmaceuticals announced on Wednesday. The once-daily oral medication is.
American Heart News - Heart News
MARCH 20, 2024
Research Highlights: Exposure to tobacco before birth and beginning smoking during childhood or adolescence were significantly associated with the development of Type 2 diabetes in adulthood, according to a study of nearly half a million adults in the.
HCPLive
MARCH 20, 2024
Idorsia Ltd. announced the FDA's approval of aprocitentan (Tryvio) for treatment-resistant hypertension on March 20, 2024.
American Heart News - Heart News
MARCH 20, 2024
Research Highlights: After 16 weeks of free, weekly home delivery of fresh produce, study participants boosted their fruit and vegetable consumption by almost ½ of a serving per day and added 42 minutes to their weekly level of physical activity. One.
CardiacWire
MARCH 20, 2024
A new AHA study shocked the world this week, suggesting that intermittent fasting might significantly increase people’s risk of cardiovascular death, sparking a wave of media coverage, and a frenzy of criticisms from the cardiologist and scientific communities. Time-restricted eating, which is a type of intermittent fasting, involves limiting eating to a specific number of hours per day (e.g. 4 or 8 hours) and fasting for the rest of the day.
Medical Xpress - Cardiology
MARCH 20, 2024
Treating anxiety and depression reduced emergency room visits and rehospitalizations among people with heart disease, according to new research published today in the Journal of the American Heart Association.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Physiologically Speaking
MARCH 20, 2024
When I read a news headline about science, I try to first apply Hanlon’s razor: not attributing to malice what can likely be explained by incompetence. This proves to be difficult almost daily, increasingly so in the age where clickbait sells. This week is no different. On Monday, several news outlets posted headlines regarding a new “study” with the alarmist claim that “8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death.” As I write t
DAIC
MARCH 20, 2024
Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as the primary testing strategy for patients with acute chest pain, are necessary for evaluating cases and determining treatment plans. Despite its importance, a substantial number of U.S. patients who require a cardiac CT miss out on receiving one due to limited access.
HCPLive
MARCH 20, 2024
New data from NIH investigators show acute respiratory distress syndrome from COVID-19 infection may trigger heart inflammation in patients.
Medical Xpress - Cardiology
MARCH 20, 2024
SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the heart tissue, a study has found. The research, published in the journal Circulation, specifically looked at damage to the hearts of people with SARS-CoV-2-associated acute respiratory distress syndrome (ARDS), a serious lung condition that can be fatal.
HCPLive
MARCH 20, 2024
The findings in this research letter allow for greater understanding of residual joint pain modulators, with the overall goal being to improve health outcomes for those with PsA.
DAIC
MARCH 20, 2024
Getty Images milla1cf Wed, 03/20/2024 - 19:16 March 20, 2024 — SARS-CoV-2 , the virus that causes COVID-19 , can damage the heart even without directly infecting the heart tissue, a National Institutes of Health -supported study has found. The research, published in the journal Circulation, specifically looked at damage to the hearts of people with SARS-CoV2-associated acute respiratory distress syndrome ( ARDS ), a serious lung condition that can be fatal.
Science Daily - Heart Disease
MARCH 20, 2024
Treating anxiety and depression significantly reduced hospital readmission and emergency room visits in people with heart disease.This may be the first study to show that treating anxiety and depression with medication or psychotherapy has a significant impact on heart disease outcomes.
DAIC
MARCH 20, 2024
milla1cf Wed, 03/20/2024 - 18:50 March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). The Freesolve BTK RMS is designed for individuals suffering from chronic limb-threatening ischemia (CLTI). CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally.
Science Daily - Heart Disease
MARCH 20, 2024
SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the heart tissue, a new study has found. The research specifically looked at damage to the hearts of people with SARS-CoV2-associated acute respiratory distress syndrome (ARDS), a serious lung condition that can be fatal. But researchers said the findings could have relevance to organs beyond the heart and also to viruses other than SARS-CoV-2.
DAIC
MARCH 20, 2024
milla1cf Wed, 03/20/2024 - 18:53 March 20, 2024 — PECA Labs , a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, has received an additional CE Mark for its exGraft family of vascular grafts , expanding its on-label use. exGraft vascular grafts are intended for use as vascular prostheses for replacement or bypass of diseased or injured vessels, and with the new clearance, exGraft now inclu
HCPLive
MARCH 20, 2024
The phase 2, proof-of-concept LEGEND trial achieved its primary efficacy endpoint for absolute reduction in HbA1c at week 24 with lanifibranor alone or in combination with empagliflozin.
The New England Journal of Medicine
MARCH 20, 2024
The authors address the issues that must be confronted if we are to integrate the use of wearable digital health technologies into clinical care in a way that provides an enduring benefit to patients.
Dr. Paddy Barrett
MARCH 20, 2024
"Frustrated, lost and confused." That was the main feedback I got back from thousands of readers when I asked them what their experience was in trying to work with existing healthcare systems to put a plan in place to prevent heart disease. This is not good. Heart disease is the leading cause of death worldwide, and with the right approaches, 80% or more can be prevented at an early age.
American College of Cardiology
MARCH 20, 2024
What is the safety and efficacy of sacubitril/valsartan when initiated during hospitalization or soon after a worsening heart failure event and among patients with HF across the spectrum of ejection fraction?
Medical Xpress - Cardiology
MARCH 20, 2024
Imagine being able to count the different types of blood cells being formed inside the tiny bones of a mouse and pinpointing the strings and clusters of cells within the bone marrow that are responsible for producing specific types of blood cells.
Frontiers in Cardiovascular Medicine
MARCH 20, 2024
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for COVID-19, has caused nearly 7 million deaths worldwide. Severe cases are marked by an aggressive inflammatory response known as hypercytokinemia, contributing to endothelial damage. Although vaccination has reduced hospitalizations, hypercytokinemia persists in breakthrough infections, emphasizing the need for disease models mimicking this response.
American College of Cardiology
MARCH 20, 2024
The ACC has selected 50 learners for its 2024-2025 Clinical Trials Research (CTR) program, of whom 28 structural heart cardiologists and surgeons will participate in the program's new REACH (Research, Equity, and Access for Cardiac Health) cohort.
Frontiers in Cardiovascular Medicine
MARCH 20, 2024
Pseudoaneurysm is a rare but lethal complication of acute myocardial infarction. In this study, we present a unique case of a patient with left ventricular free wall rupture detected by cardiac magnetic resonance more than 1 year after a percutaneous transluminal coronary intervention.
HCPLive
MARCH 20, 2024
A recent comparison of changes in Lp(a) mass and molar concentrations found that each assay method was similarly predictive of MACE reductions with alirocumab.
American College of Cardiology
MARCH 20, 2024
Commentary based on Chao CJ, Jeong J, Arsanjani R, et al. Echocardiography-based deep learning model to differentiate constrictive pericarditis and restrictive cardiomyopathy.
HCPLive
MARCH 20, 2024
In an interview with HCPLive, Rebecca Andrews, MD, provided insight into the way the American College of Physicians voted on the performance measures for MDD.
American College of Cardiology
MARCH 20, 2024
In this week’s View, Dr. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI. He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis.
HCPLive
MARCH 20, 2024
Jake Leach, COO of Dexcom, joins the podcast to discuss the historic clearance of the Stelo sensor and other updates in CGM from the company.
Medical Xpress - Cardiology
MARCH 20, 2024
Shaunté Brewer didn't know that her health was in danger at age 13. As the Chicago resident recalls, she was more focused on passing her softball test in gym than on her prevalent cough. Fortunately, Brewer's mother determined that the sound and persistence of her daughter's cough called for a trip to the hospital.
HCPLive
MARCH 20, 2024
Vice Chair of the Performance Measurement Committee Rebecca A. Andrews spoke to HCPLive about the challenges with performance measures for treating major depressive disorder.
Journal of Cardiothoracic Surgery
MARCH 20, 2024
Obstruction and/or reflux compromise during venous emptying can facilitate different pathophysiologies in chronic venous insufficiency (CVI). We present a patient with persistent lower limb CVI edema caused by.
HCPLive
MARCH 20, 2024
These data on patients with psoriatic arthritis point to risk levels for new adalimumab users as well as users of ustekinumab and etanercept.
All About Cardiovascular System and Disorders
MARCH 20, 2024
Transcript of the video: Conventional balloon angioplasty enlarges the vessel a bit as well as plasters the plaque on to the vessel wall, while laser angioplasty is a new technique, also known as laser atherectomy, in which excimer laser, which is a monochromatic source of light, is used to vaporize the plaque or thrombus by producing heat and shock waves.
HCPLive
MARCH 20, 2024
An analysis of data from more than 5 million people suggests rheumatic and immune-mediated diseases were associated with increased rates of childlessness and elevated risk of adverse pregnancy outcomes.
All About Cardiovascular System and Disorders
MARCH 20, 2024
Transcript of the video: Now we will discuss the basic principles of evaluation of jugular venous pressure and jugular venous pulse. These are assessed in the internal jugular vein and not in the external jugular vein. To revise the anatomy lessons, this is the external jugular vein and this is the internal jugular vein. Now, why we should not be looking at external jugual vein, though it is much easier to find out is that, in lower portion, it may be kinked so that it may not reflect the true r
Expert insights. Personalized for you.
144 
Let's personalize your content